Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2009-05-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants
NCT00642863
Neurodevelopment After Early Iron Supplementation
NCT00457990
Iron Supplement Effect on Child Development
NCT02690675
Timing of Iron Supplementation in Very Low Birth Weight Infants
NCT00683527
to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants
NCT03171324
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
low iron dose
iron
High, intermediate and low iron dosage orally for 2 months
2
intermediate iron dose
iron
High, intermediate and low iron dosage orally for 2 months
3
High Iron dose
iron
High, intermediate and low iron dosage orally for 2 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iron
High, intermediate and low iron dosage orally for 2 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Torch infections
* Infants with hearing disorders
* Infants receiving erythropoietin
* Infants with subnormal vitamin E levels
* Infants with severe anemia
* Infants who are not on full feeds
* Infant with in-utero exposure to cocaine
32 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanjiv B Amin, MD MS
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester Medical Center
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Piron Trial
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.